scholarly journals Transcriptional suppression of CD8 + T cell exhaustion for improving T cell immunotherapy

2021 ◽  
Author(s):  
Xue Yang ◽  
Bingjing Wang ◽  
Xuetao Cao

Cancers ◽  
2021 ◽  
Vol 13 (3) ◽  
pp. 515
Author(s):  
Sungmin Jung ◽  
Jea-Hyun Baek

T cell factor 1 (TCF1) is a transcription factor that has been highlighted to play a critical role in the promotion of T cell proliferation and maintenance of cell stemness in the embryonic and CD8+ T cell populations. The regulatory nature of TCF1 in CD8+ T cells is of great significance, especially within the context of T cell exhaustion, which is linked to the tumor and viral escape in pathological contexts. Indeed, inhibitory signals, such as programmed cell death 1 (PD-1) and cytotoxic-T-lymphocyte-associated protein 4 (CTLA-4), expressed on exhausted T lymphocytes (TEX), have become major therapeutic targets in immune checkpoint blockade (ICB) therapy. The significance of TCF1 in the sustenance of CTL-mediated immunity against pathogens and tumors, as well as its recently observed necessity for an effective anti-tumor immune response in ICB therapy, presents TCF1 as a potentially significant biomarker and/or therapeutic target for overcoming CD8+ T cell exhaustion and resistance to ICB therapy. In this review, we aim to outline the recent findings on the role of TCF1 in T cell development and discuss its implications in anti-tumor immunity.



2013 ◽  
Vol 42 (3) ◽  
pp. 204-220 ◽  
Author(s):  
Stephanie R. Jackson ◽  
Melissa M. Berrien-Elliott ◽  
Jennifer M. Meyer ◽  
E. John Wherry ◽  
Ryan M. Teague




Cytokine ◽  
2012 ◽  
Vol 59 (3) ◽  
pp. 512
Author(s):  
Y. Wang ◽  
M. Swiecki ◽  
M. Cella ◽  
G. Alber ◽  
R.D. Schreiber ◽  
...  


2015 ◽  
Vol 195 (7) ◽  
pp. 3100-3109 ◽  
Author(s):  
Min Li ◽  
Rui Sun ◽  
Long Xu ◽  
Wenwei Yin ◽  
Yongyan Chen ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document